documents: EPA-HQ-OAR-2002-0095-0025
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-HQ-OAR-2002-0095-0025 | EPA | EPA-HQ-OAR-2002-0095 | C. J. Morris and M. D. Woolf, Piper & Marbury L.L.P., Washington, DC on behalf of Aeropharm Technology, Inc., Edison, NJ. Application of Aeropharm Technology, Inc. For an Essential Use Exemption to the Phase-Out of Ozone-Depleting Substances. [A-93-39-II-A-1] | Supporting & Related Material | Report | 2022-06-30T04:00:00Z | 2022 | 6 | 2022-07-01T03:45:16Z | 0 | 0 | 0900006483d7eb6d |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref